MENLO PARK, Calif., Aug. 2, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2023 . Second quarter results Revenue of $47.6 million, a 34% increase compared with $35.5 million in the prior year-period.Recognized revenue on 47 sequencing systems in the second quarter,…Read More
Pacific Biosciences of California Inc PacBio Announces Second Quarter 2023 Financial Results
